Orion Infusion Ltd (ORIN)

Currency in BDT
260.10
-5.00(-1.89%)
Closed·
Trading near 52-week Low
ORIN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
257.50268.00
52 wk Range
257.50587.50
Key Statistics
Prev. Close
390.7
Open
265.1
Day's Range
257.5-268
52 wk Range
257.5-587.5
Volume
262.78K
Average Volume (3m)
201.05K
1-Year Change
-43.4442%
Book Value / Share
16.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORIN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
May 10, 2026
EPS / Forecast
0.27 / --
Revenue / Forecast
83.61M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.74%
Dividend Yield
0.51%
Industry Median 4.03%
Annualized payout
2.00
Paid unevenly
5-Years Growth
+14.87%
Growth Streak

ORIN Income Statement

Compare ORIN to Peers and Sector

Metrics to compare
ORIN
Peers
Sector
Relationship
P/E Ratio
149.1x10.2x−0.4x
PEG Ratio
−10.760.010.00
Price/Book
16.0x1.4x2.6x
Price / LTM Sales
8.2x2.3x3.1x
Upside (Analyst Target)
-27.4%48.3%
Fair Value Upside
Unlock7.9%6.2%Unlock

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isotonic solution; Intralipid 10, a fat emulsion for intravenous use; Maprocin, a fluorinated quinolone antimicrobial agent; and Salpac, a sterile and nonpyrogenic solution. The company was formerly known as Mala Chemical & Pharmaceuticals Industries Ltd. and changed its name to Orion Infusion Limited in 1994. Orion Infusion Limited was incorporated in 1983 and is based in Dhaka, Bangladesh.

Employees
563

FAQ

What Is the Orion Infusion (ORIN) Stock Price Today?

The Orion Infusion stock price today is 260.10 BDT.

What Stock Exchange Does Orion Infusion Trade On?

Orion Infusion is listed and trades on the Dhaka Stock Exchange.

What Is the Stock Symbol for Orion Infusion?

The stock symbol for Orion Infusion is "ORIN."

Does Orion Infusion Pay Dividends? What’s The Current Dividend Yield?

The Orion Infusion dividend yield is 0.79%.

What Is the Orion Infusion Market Cap?

As of today, Orion Infusion market cap is 5.30B BDT.

What Is Orion Infusion's Earnings Per Share (TTM)?

The Orion Infusion EPS (TTM) is 1.74.

From a Technical Analysis Perspective, Is ORIN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Orion Infusion Stock Split?

Orion Infusion has split 1 times.

How Many Employees Does Orion Infusion Have?

Orion Infusion has 563 employees.

What is the current trading status of Orion Infusion (ORIN)?

As of Aug 16, 2026, Orion Infusion (ORIN) is trading at a price of 260.10 BDT, with a previous close of 390.70 BDT. The stock has fluctuated within a day range of 257.50 BDT to 268.00 BDT, while its 52-week range spans from 257.50 BDT to 587.50 BDT.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.